These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24748047)

  • 1. Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements.
    Kato D; Takashima H; Waseda K; Kurita A; Kuroda Y; Kosaka T; Kuhara Y; Ando H; Maeda K; Kumagai S; Sakurai S; Suzuki A; Toda Y; Watanabe A; Sato S; Fujimoto M; Mizuno T; Amano T
    Heart Vessels; 2015 Jul; 30(4):477-83. PubMed ID: 24748047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of additional intracoronary nicorandil administration during fractional flow reserve measurement with intravenous adenosine 5'-triphosphate infusion.
    Takami H; Sonoda S; Muraoka Y; Sanuki Y; Kashiyama K; Fukuda S; Oginosawa Y; Tsuda Y; Araki M; Otsuji Y
    J Cardiol; 2017 Jan; 69(1):119-124. PubMed ID: 26947100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility and Validity of Intracoronary Administration of Nicorandil Alone for the Measurement of Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis.
    Ishibuchi K; Fujii K; Otsuji S; Takiuchi S; Hasegawa K; Tamaru H; Ishii R; Yasuda S; Nakabayashi S; Yamamoto W; Kusumoto H; Taniguchi Y; Kakishita M; Shimatani Y; Higashino Y
    Circ J; 2019 Sep; 83(10):2010-2016. PubMed ID: 31413232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive value of nicorandil on ATP for further inducing hyperemia in patients with an intermediate coronary artery stenosis.
    Kobayashi Y; Okura H; Neishi Y; Higa T; Kobayashi Y; Uemura S; Yoshida K
    Coron Artery Dis; 2017 Mar; 28(2):104-109. PubMed ID: 27611876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of fractional flow reserve according to the methods of hyperemia induction.
    Lim WH; Koo BK; Nam CW; Doh JH; Park JJ; Yang HM; Park KW; Kim HS; Takashima H; Waseda K; Amano T; Kato D; Kurita A; Oi M; Toyofuku M; van Nunen L; Pijls NH
    Catheter Cardiovasc Interv; 2015 May; 85(6):970-6. PubMed ID: 25413590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of nicorandil for the measurement of coronary fractional flow reserve.
    Oi M; Toyofuku M; Matsumura Y; Motohashi Y; Takahashi K; Kawase Y; Ko E; Tanaka M; Kitada M; Yuzuki Y; Tamura T; Tanaka N; Kimura T
    Cardiovasc Interv Ther; 2014 Jan; 29(1):24-30. PubMed ID: 24002893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study.
    Nishi T; Kitahara H; Fujimoto Y; Nakayama T; Nagashima K; Hanaoka H; Kobayashi Y
    Heart Vessels; 2018 Dec; 33(12):1570-1575. PubMed ID: 29858919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve.
    Nishi T; Kitahara H; Iwata Y; Fujimoto Y; Nakayama T; Takahara M; Sugimoto K; Kobayashi Y
    J Cardiol; 2016 Dec; 68(6):512-516. PubMed ID: 26811149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hyperemic efficacy between central and peripheral venous adenosine infusion for fractional flow reserve measurement.
    Seo MK; Koo BK; Kim JH; Shin DH; Yang HM; Park KW; Lee HY; Kang HJ; Kim HS; Oh BH; Park YB
    Circ Cardiovasc Interv; 2012 Jun; 5(3):401-5. PubMed ID: 22647519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility and safety of intracoronary nicorandil as a hyperemic agent for the measurement of fractional flow reserve.
    Chhabria R; Mehta NP; Jain N; Handa SR; Mehta AB
    Indian Heart J; 2020; 72(6):603-605. PubMed ID: 33357653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
    Inoue K; Sonoda S; Naka Y; Okabe H; Setoyama K; Miura T; Anai R; Araki M; Kataoka M
    Int Heart J; 2021 Sep; 62(5):962-969. PubMed ID: 34544970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment.
    Verdoia M; Erbetta R; Sagazio E; Barbieri L; Negro F; Suryapranata H; Kedhi E; De Luca G;
    Int J Cardiol; 2019 Jun; 284():16-21. PubMed ID: 30293665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study.
    Leone AM; Porto I; De Caterina AR; Basile E; Aurelio A; Gardi A; Russo D; Laezza D; Niccoli G; Burzotta F; Trani C; Mazzari MA; Mongiardo R; Rebuzzi AG; Crea F
    JACC Cardiovasc Interv; 2012 Apr; 5(4):402-8. PubMed ID: 22516396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness and safety of intracoronary administration of nicorandil for evaluating fractional flow reserve in Japanese patients.
    Tanaka N; Takahashi Y; Ishihara H; Kawakami T; Ono H
    Clin Cardiol; 2015 Jan; 38(1):20-4. PubMed ID: 25626396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis.
    Lee JM; Kato D; Oi M; Toyofuku M; Takashima H; Waseda K; Amano T; Kurita A; Ishihara H; Lim WH; Doh JH; Nam CW; Tanaka N; Koo BK; Tanaka N
    EuroIntervention; 2016 Jun; 12(2):e208-15. PubMed ID: 27290680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate.
    Nakayama M; Chikamori T; Uchiyama T; Kimura Y; Hijikata N; Ito R; Yuhara M; Sato H; Kobori Y; Yamashina A
    Cardiovasc Interv Ther; 2018 Apr; 33(2):116-124. PubMed ID: 28110424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory.
    Jang HJ; Koo BK; Lee HS; Park JB; Kim JH; Seo MK; Yang HM; Park KW; Nam CW; Doh JH; Kim HS
    Eur Heart J; 2013 Jul; 34(27):2055-62. PubMed ID: 23396491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intravenous nicorandil for fractional flow reserve assessment: study protocol for a crossover randomised trial.
    Nishi T; Kitahara H; Fujimoto Y; Nakayama T; Sugimoto K; Nagashima K; Hanaoka H; Kobayashi Y
    BMJ Open; 2016 Nov; 6(11):e012737. PubMed ID: 27872119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of caffeine intake on intravenous adenosine-induced fractional flow reserve.
    Kasumi I; Fujii K; Satoru O; Shin T; Katsuyuki H; Hiroto T; Rui I; Shingo Y; Sho N; Wataru Y; Hirofumi K; Yusuke T; Mikio K; Yuji S; Yorihiko H
    J Cardiol; 2020 Nov; 76(5):472-478. PubMed ID: 32532583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Plaque Characteristics Relate More Strongly With Hyperemic Fractional Flow Reserve and Instantaneous Wave-Free Ratio Than With Resting Instantaneous Wave-Free Ratio.
    Driessen RS; de Waard GA; Stuijfzand WJ; Raijmakers PG; Danad I; Bom MJ; Min JK; Leipsic JA; Ahmadi A; van de Ven PM; Knuuti J; van Rossum AC; Davies JE; van Royen N; Narula J; Knaapen P
    JACC Cardiovasc Imaging; 2020 Mar; 13(3):746-756. PubMed ID: 31422133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.